| Market Cap | 799M 710M 663M 604M 1.14B 76.8B 1.15B 8.02B 3.11B 39.26B 3B 2.93B 126B | P/E 2023 |
2,007x | P/E 2024 | -3.42x |
|---|---|---|---|---|---|
| Enterprise Value | 964M 857M 800M 729M 1.37B 92.69B 1.39B 9.68B 3.75B 47.39B 3.62B 3.54B 152B | EV / Sales 2023 |
8.58x | EV / Sales 2024 | 4.64x |
| Free-Float |
98.58% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -2.83% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 15/09/2025 | |
Richard McAvoy
DFI | Director of Finance/CFO | - | 01/06/2026 |
David Stewart
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.83% | +7.69% | - | - | 799M | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.97% | -3.39% | +26.07% | +58.90% | 410.8B | |
| Weighted average by Cap. | -0.60% | -3.33% | +29.07% | +71.15% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 149M 133M 124M 113M 213M 14.35B 215M 1.5B 580M 7.34B 560M 548M 23.54B | 140M 124M 116M 106M 199M 13.45B 201M 1.4B 544M 6.88B 525M 514M 22.07B |
| Net income | 560K 498K 464K 423K 798K 53.83M 806K 5.62M 2.18M 27.52M 2.1M 2.06M 88.32M | -141M -125M -117M -106M -201M -13.53B -203M -1.41B -547M -6.92B -528M -517M -22.2B |
| Net Debt | 151M 134M 125M 114M 216M 14.54B 218M 1.52B 588M 7.43B 568M 555M 23.85B | 165M 147M 137M 125M 236M 15.89B 238M 1.66B 643M 8.12B 621M 607M 26.08B |
Employees
-
Sector
Pharmaceuticals
